Humalog (Eli Lilly and Company)


Welcome to the PulseAid listing for the Humalog drug offered from Eli Lilly and Company. This Insulin [Chemical/Ingredient],Insulin Analog [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Eli Lilly and Company
NON-PROPRIETARY NAME: Insulin lispro
SUBSTANCE NAME: INSULIN LISPRO
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Insulin [Chemical/Ingredient],Insulin Analog [EPC]
ROUTE: INTRAVENOUS; SUBCUTANEOUS
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1996-06-14
END MARKETING DATE: 0000-00-00


Humalog HUMAN PRESCRIPTION DRUG Details:

Item DescriptionHumalog from Eli Lilly and Company
LABELER NAME: Eli Lilly and Company
DEA SCHEDULE:
ACTIVE STRENGTH: 100([iU]/mL)
START MARKETING DATE: 1996-06-14
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0002-7510_5b040825-3777-4cc2-a30a-34aa47a7b7d5
PRODUCT NDC: 0002-7510
APPLICATION NUMBER: NDA020563

Other INSULIN LISPRO Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Dispensing Solutions, Inc.Humalog
Eli Lilly and CompanyHumalog
Physicians Total Care, Inc.Humalog